Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted ...

The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...

Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

For patients with metastatic prostate cancer who have exhausted initial or first-line treatments like hormone therapy (also called androgen deprivation therapy or ADT) and chemotherapy, a promising ...

CINCINNATI (WKRC) - Doctors at the Urology Group are pioneering the use of artificial intelligence to enhance prostate cancer treatment, offering patients like Terry Hawk a new level of targeted ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to manage this advanced prostate cancer.

Add Yahoo as a preferred source to see more of our stories on Google. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to compare ...